- Home
- FORR vs INO Comparison
FORR vs INO Comparison
Compare FORR & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- INO
- Stock Information
- Founded
- FORR 1983
- INO 1979
- Country
- FORR United States
- INO United States
- Employees
- FORR N/A
- INO N/A
- Industry
- FORR Diversified Commercial Services
- INO Medical/Dental Instruments
- Sector
- FORR Consumer Discretionary
- INO Health Care
- Exchange
- FORR Nasdaq
- INO Nasdaq
- Market Cap
- FORR 169.1M
- INO 136.6M
- IPO Year
- FORR 1996
- INO 1998
- Fundamental
- Price
- FORR $8.82
- INO $2.61
- Analyst Decision
- FORR
- INO Buy
- Analyst Count
- FORR 0
- INO 5
- Target Price
- FORR N/A
- INO $8.80
- AVG Volume (30 Days)
- FORR 96.4K
- INO 1.0M
- Earning Date
- FORR 10-30-2025
- INO 11-10-2025
- Dividend Yield
- FORR N/A
- INO N/A
- EPS Growth
- FORR N/A
- INO N/A
- EPS
- FORR N/A
- INO N/A
- Revenue
- FORR $412,103,000.00
- INO $182,337.00
- Revenue This Year
- FORR N/A
- INO N/A
- Revenue Next Year
- FORR $1.51
- INO $14,751.49
- P/E Ratio
- FORR N/A
- INO N/A
- Revenue Growth
- FORR N/A
- INO N/A
- 52 Week Low
- FORR $8.45
- INO $1.30
- 52 Week High
- FORR $17.65
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- FORR 42.36
- INO 60.39
- Support Level
- FORR $8.80
- INO $2.44
- Resistance Level
- FORR $9.39
- INO $2.67
- Average True Range (ATR)
- FORR 0.31
- INO 0.13
- MACD
- FORR 0.03
- INO 0.01
- Stochastic Oscillator
- FORR 30.24
- INO 94.50
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.